Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Increases By 184.3%

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) saw a large increase in short interest in the month of December. As of December 31st, there was short interest totaling 115,921 shares, an increase of 184.3% from the December 15th total of 40,770 shares. Based on an average daily trading volume, of 141,392 shares, the days-to-cover ratio is currently 0.8 days. Based on an average daily trading volume, of 141,392 shares, the days-to-cover ratio is currently 0.8 days.

Conduit Pharmaceuticals Trading Up 28.4%

Conduit Pharmaceuticals stock opened at $0.01 on Thursday. Conduit Pharmaceuticals has a 12-month low of $0.01 and a 12-month high of $0.02. The firm’s fifty day moving average is $0.01 and its 200 day moving average is $0.01.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.